TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/17/23 16:30 | 11/15/23 | INVA | Innoviva, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zhen Marianne | CA | O | Chief Ac | S | -154 | 13.99 | 0 | -11 | -21 | 40 | D | ||||||||||||||
8/24/21 11:50 | 8/20/21 | INVA | Innoviva, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zhen Marianne | CA | O | Chief Ac | S.a | -18 | 15.89 | 0 | -1 | -3 | 35 | D | ||||||||||||||
8/23/21 17:02 | 8/19/21 | INVA | Innoviva, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zhen Marianne | CA | O | Chief Ac | S.m | -63 | 15.98 | 0 | -4 | -10 | 35 | D | ||||||||||||||
2/24/20 16:40 | 2/24/20 | INVA | Innoviva, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zhen Marianne | CA | O | Chief Ac | S | -44 | 14.78 | 0 | -3 | -12 | 22 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |